PI
MRNA icon

PineBridge Investments’s Moderna MRNA Stock Holding History

PineBridge Investments’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,308
Closed -$434K – 677
2025
Q1 		$434K Sell
15,308
-338
-2% -$12K ﹤0.01% 685
2024
Q4 		$651K Sell
15,646
-22,700
-59% -$1.08M ﹤0.01% 658
2024
Q3 		$2.56M Sell
38,346
-4,485
-10% -$412K 0.02% 405
2024
Q2 		$5.09M Sell
42,831
-47,814
-53% -$6.05M 0.04% 306
2024
Q1 		$9.66M Buy
90,645
+33,652
+59% +$3.39M 0.08% 249
2023
Q4 		$5.67M Buy
56,993
+10,502
+23% +$883K 0.05% 279
2023
Q3 		$4.8M Sell
46,491
-51,489
-53% -$5.74M 0.05% 267
2023
Q2 		$11.9M Sell
97,980
-2,079
-2% -$277K 0.13% 161
2023
Q1 		$15.4M Sell
100,059
-4,787
-5% -$790K 0.17% 150
2022
Q4 		$18.8M Sell
104,846
-2,710
-3% -$443K 0.23% 128
2022
Q3 		$12.7M Buy
107,556
+52,693
+96% +$8M 0.16% 155
2022
Q2 		$7.84M Buy
54,863
+20,533
+60% +$2.93M 0.1% 211
2022
Q1 		$5.91M Sell
34,330
-5,627
-14% -$947K 0.06% 264
2021
Q4 		$10.1M Buy
39,957
+13,886
+53% +$4.06M 0.1% 201
2021
Q3 		$10M Buy
+26,071
New +$9.62M 0.12% 183
2021
Q1 		– Sell
-13
Closed -$1K – 688
2020
Q4 		$1K Buy
+13
New +$1.31K ﹤0.01% 650
2020
Q3 		– Sell
-22
Closed -$1K – 684
2020
Q2 		$1K Buy
+22
New +$1.21K ﹤0.01% 627

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

PineBridge Investments's MRNA Position: Q2 2025 in Review

PineBridge Investments sold out of Moderna (MRNA) in Q2 2025, closing a stake of 15,308 shares — an estimated $434K sold.

PineBridge Investments first reported a position in MRNA in Q2 2020 and held it in 17 quarters. The position peaked at $18.8M in Q4 2022. 674 funds tracked by Wall St. Rank hold MRNA as of Q2 2025.

  • PineBridge Investments reported no remaining Moderna position as of Q2 2025 after selling out during the quarter.
  • PineBridge Investments sold 15,308 Moderna shares in Q2 2025, an estimated $434K.
  • PineBridge Investments first reported a position in Moderna in Q2 2020 and held it in 17 quarters.
  • PineBridge Investments's Moderna position peaked at $18.8M in Q4 2022.
  • 674 funds tracked by Wall St. Rank held Moderna as of Q2 2025.

Based on PineBridge Investments's 13F filing for Q2 2025, filed 13 Aug 2025.